Skip to main content

AstreAdept® Chromatography Technology

Your basket

Your basket is empty. Continue shopping to add products to your basket.

Search our catalogue

Call Centre

Request Quote

Please enter the quantity of products you want a quote for

Please enter the date you need these products byPlease enter a date in the format DD/MM/YYYY

View Content

Please complete the form below to receive the requested content from Astrea Bioseparations. We will use the data you provide to send you relevant updates, special offers, and product-related information. See our Privacy Notice for details on how we use personal data.

If you have an account please log in to gain access to content. You can apply for an account here

Please enter a First Name

Please enter a valid First Name, the maximum length is 50 characters.

Please enter a Last Name

Please enter a valid Last Name, the maximum length is 50 characters.

Please enter a Company Name

Please enter a valid Company, the maximum length is 100 characters

Please enter a valid Email AddressPlease enter a valid Email AddressThe Email Address entered is already registered, please sign in with the Email Address or enter a different one

Please select a valid Telephone Number, the maximum length is 30 characters

Please enter a valid Telephone Number consisting only of the following characters and spaces ( ) + 0 1 2 3 4 5 6 7 8 9

Please select a State / Province / Territory

Please select a valid State / Province / Territory, the maximum length is 150 characters

Please select a Country

Data entered into form will be stored in your session (not in a cookie) to avoid having to re-enter in future form submissions.

AstreAdept® Chromatography Technology

Cell and gene therapy modalities are magnitudes larger than small molecule or recombinant protein-based therapies. Legacy technologies are suitable for monoclonal antibodies but not for modalities such as lentiviral vectors, exosomes or plasmids. Our AstreAdept® technology has been developed to meet the needs of cell and gene therapy developers to accelerate the commercialization of novel therapies.

 

 

Capacity Without Compromise

Higher recovery reduces pressure to expand upstream production

Higher capacity and faster runs compresses bioprocessing, positively impacting on process economics

Smaller devices reduce physical footprint, reducing facility to use, water usage and waste removal, leading to greener manufacturing

 
  • Amplifying downstream processing efficiency
  • Flexible solutions for diverse modalities
  • Intensified productivity
  • Supplied in pre-packed columns
  • Compatible with existing chromatography systems 

 

Close

Purify larger modalities with higher productivity for downstream processing and bring the advantages of AstreAdept® to manufacturing scale

Lentivirus

Exosomes

Plasmid DNA




Any questions? 

Request a follow-up and one of our experts will contact you directly:


Call Centre Product Compare